U.S. Beverage Stock News

NYSE:NIO
NYSE:NIOAuto

NIO (NIO) Posts Rare Q4 Profit Challenging Persistent Loss-Making Narrative

NIO (NIO) has closed out FY 2025 with Q4 revenue of C¥34.7b and basic EPS of C¥0.05, alongside trailing twelve month revenue of C¥87.5b and a trailing basic EPS loss of C¥6.85. This puts a spotlight on how quickly the earnings line is moving relative to the top line. The company has seen quarterly revenue move from C¥19.7b and a basic EPS loss of C¥3.45 in Q4 2024 to C¥34.7b and basic EPS of C¥0.05 in Q4 2025. Over the same period, trailing twelve month revenue shifted from C¥65.7b with a...
NYSE:ADCT
NYSE:ADCTBiotechs

ADC Therapeutics (ADCT) Loss Narrowing To US$0.04 EPS Challenges Bearish Profitability Narrative

ADC Therapeutics (ADCT) closed out FY 2025 with Q4 revenue of US$23.1 million and a basic EPS loss of US$0.04, alongside net income excluding extra items of a US$6.4 million loss. The company has seen quarterly revenue move from US$16.9 million in Q4 2024 to US$23.1 million in Q4 2025, while basic EPS losses shifted from US$0.29 to US$0.04 over the same period. This sets the stage for investors to focus on how these headline figures translate into the quality and direction of margins. See our...
NYSE:GBCI
NYSE:GBCIBanks

Did Softer Margins And EPS Pressure Just Shift Glacier Bancorp's (GBCI) Investment Narrative?

In recent months, Glacier Bancorp reported softer quarterly results, with net interest income growth trailing the wider banking industry and earnings per share falling even as revenue increased. This divergence between rising revenue and declining per-share earnings has raised questions about the bank’s efficiency, cost structure, and overall profitability quality. With concerns mounting over weaker quarterly performance and profitability trends, we’ll now examine how this development...
NYSE:NPK
NYSE:NPKAerospace & Defense

Does National Presto (NPK) Holding Its Dividend Signal Enduring Defense Strength Or Mask Tariff Strains?

National Presto Industries, Inc. has affirmed an annual cash dividend of US$1.00 per share, with an ex-dividend and record date of March 9, 2026, and payment scheduled for March 20, 2026. The dividend decision comes after the company reported very strong 2025 net sales growth driven by fulfilling a sizable Defense segment backlog, while its Housewares/Small Appliance business contended with tariff-related pressures on demand and costs. Next, we’ll examine how the Defense segment’s...
NasdaqGS:VECO
NasdaqGS:VECOSemiconductor

Does Veeco (VECO) Becoming InP Laser “Tool of Record” Recast Its AI Datacom Narrative?

In early March 2026, Veeco Instruments Inc. reported that a global leader in optical communications and laser manufacturing placed orders for multiple Lumina Metal Organic Chemical Vapor Deposition systems and Spector Ion Beam Sputtering Optical Coating systems to produce indium phosphide lasers for datacom applications. This order effectively designates Lumina as the customer’s production tool of record for InP epitaxy, underlining Veeco’s role in enabling optical transceivers that connect...
NYSE:RSI
NYSE:RSIHospitality

Has Rush Street Interactive (RSI) Run Too Far After Its 108% One-Year Rally?

If you are wondering whether Rush Street Interactive's share price still makes sense after a strong run, looking closely at what you are paying for today versus the underlying fundamentals is a useful place to start. The stock last closed at US$20.73, with returns of 3.9% over the past 7 days, 17.3% over the past 30 days, 7.4% year to date, 108.1% over the past year and a very large gain over 3 years. Recent coverage around Rush Street Interactive has focused on its position in online gaming...
NasdaqCM:SBET
NasdaqCM:SBETHospitality

SharpLink Gaming (SBET) Q3 Profit Swing Challenges Longstanding Loss‑Focused Narratives

Sharplink (NasdaqCM:SBET) just posted its FY 2025 third quarter numbers with total revenue of about US$10.8 million and basic EPS of US$0.70, a sharp contrast to the trailing twelve month EPS of a US$0.02 loss on revenue of roughly US$13.1 million. Over recent quarters the company has reported revenue of roughly US$0.7 million, then US$0.8 million, and most recently US$10.8 million. Over the same period, quarterly EPS has moved from losses of around US$3.08 per share to US$4.27 per share to a...
NYSE:LW
NYSE:LWFood

Starboard Pressure On Lamb Weston Cost Cuts And Asset Sales Meets Valuation Gap

Starboard Value LP has publicly urged Lamb Weston Holdings to increase its cost savings program, with a heavier focus on SG&A expenses. The activist investor is also pressing the company to review its international footprint, including the possibility of divesting select APAC assets. This push could influence Lamb Weston Holdings' capital allocation priorities and operating approach in the near term. For investors watching NYSE:LW, this development follows a challenging share price period,...
NasdaqGS:COKE
NasdaqGS:COKEBeverage

Assessing Coca-Cola Consolidated (COKE) Valuation After Independence Deal And Strong Fundamental Performance

Coca-Cola Consolidated (COKE) has drawn fresh attention after fully buying out Coca-Cola's equity interest for US$2.4b last November. This move leaves the bottler operating as an independent company. See our latest analysis for Coca-Cola Consolidated. The independence deal is landing against a strong run in Coca-Cola Consolidated's shares, with the stock at US$206.91 and a 30-day share price return of 31.17% alongside a 1-year total shareholder return of 69.85%. This suggests momentum has...
NasdaqGM:VCEL
NasdaqGM:VCELBiotechs

Is Vericel (VCEL) Pricing Justified After A 30% One-Year Share Price Decline

If you are trying to work out whether Vericel is attractively priced today, it helps to step back and look at both its recent share performance and what the numbers say about value. Vericel shares last closed at US$34.12, with returns of 3.5% decline over 7 days, 5.7% decline over 30 days, a 4.2% decline year to date and a 30.2% decline over the last year, while the 3 year return is 15.3% and the 5 year return is 28% decline. Recent price moves sit against a backdrop of ongoing interest in...
NasdaqGS:KRYS
NasdaqGS:KRYSBiotechs

The Bull Case For Krystal Biotech (KRYS) Could Change Following Q4 Beat And CEO Stock Sales

In recent weeks, Krystal Biotech reported financial results for the fourth quarter of 2025 that exceeded analyst expectations for both earnings and revenue, while President and CEO Krishnan Krish S executed US$6.58 million of pre-planned stock sales under a Rule 10b5-1 trading plan. This combination of financial outperformance and insider selling offers fresh insight into how management is monetizing equity while the core business appears to be executing ahead of external forecasts. Next,...
NasdaqGS:IMCR
NasdaqGS:IMCRBiotechs

Will Immunocore's (IMCR) 2025 Revenue Growth and Narrower Loss Reshape Its Investment Narrative?

Immunocore Holdings plc recently reported fourth-quarter 2025 revenue of US$104.48 million and a quarterly net loss of US$30.06 million, alongside full-year 2025 revenue of US$400.02 million and a full-year net loss of US$35.51 million. The company paired this earnings update with a packed schedule of March 2026 healthcare conference appearances in Boston and Miami, signaling active engagement with investors and the broader biotech community. We’ll now examine how the full-year revenue...
NYSE:PINE
NYSE:PINEREITs

Should Alpine’s New High‑Coupon Mortgage Loan Strategy Shape How Investors View PINE’s Risk Profile?

Alpine Income Property Trust, Inc. recently originated a US$32.0 million first mortgage loan, funding US$8.6 million at close, to back the development of an 11‑acre, 101,000‑square‑foot retail center with investment grade tenants and three outparcels in the Covington Town Center master plan near Atlanta. The high‑coupon, 24‑month loan tied to a Target‑anchored project adjacent to an existing Publix highlights Alpine’s growing use of higher‑yield structured financing alongside its net lease...
NasdaqCM:RLMD
NasdaqCM:RLMDPharmaceuticals

A Look At Relmada Therapeutics (RLMD) Valuation After NDV‑01 Phase 2 Bladder Cancer Data

Phase 2 NDV-01 data and what it could mean for Relmada Therapeutics (RLMD) Relmada Therapeutics (RLMD) has drawn fresh attention after reporting 12 month interim Phase 2 data for NDV-01 in high risk non muscle invasive bladder cancer, showing strong complete response rates and a favorable safety profile. See our latest analysis for Relmada Therapeutics. The NDV-01 update and recent Leerink healthcare conference appearance came alongside a sharp shift in sentiment, with Relmada Therapeutics’ 1...
NasdaqGS:CCOI
NasdaqGS:CCOITelecom

Will Cogent’s Refinancing And Data Center Monetization Plan Change Cogent Communications Holdings' (CCOI) Narrative

Cogent Communications Holdings recently outlined a multi-step refinancing and balance sheet restructuring plan, including moving about US$569 million of IRU-backed obligations into an infrastructure entity and preparing to refinance US$750 million of unsecured 2027 notes. The company is also converting Sprint-acquired data center assets and pursuing a potential sale of 10 facilities to a global infrastructure fund, with all proceeds earmarked to strengthen collateral and reduce financing...
OTCPK:TYFG
OTCPK:TYFGBanks

Tri-County Financial Group FY 2025 Margin Improvement Challenges Longer Term Profit Decline Narratives

Tri-County Financial Group (OTCPK:TYFG) has wrapped up FY 2025 with fourth quarter revenue of US$17.8 million and basic EPS of US$1.64, alongside trailing twelve month revenue of US$66.7 million and EPS of US$5.73 that sit against a 31% year over year earnings increase and a net profit margin of 20.5%. Over recent periods the company has seen revenue move from US$59.8 million and EPS of US$4.32 on a trailing basis in Q4 2024 to US$66.7 million and EPS of US$5.73 by Q4 2025, with margins...
NYSE:CURB
NYSE:CURBRetail REITs

Assessing Whether Curbline Properties (CURB) Is Mispriced After Recent Trading Moves

Why Curbline Properties Is On Investor Radar Today Curbline Properties (CURB) has drawn attention after recent trading left the stock with a 1 day return of 1.68% and a 7 day decline of 4.61%. This price movement has prompted fresh interest in its valuation. See our latest analysis for Curbline Properties. While the 7 day share price return of negative 4.61% has cooled sentiment, the 90 day share price return of 16.64% and 1 year total shareholder return of 18.72% point to momentum that has...
NasdaqGS:BCPC
NasdaqGS:BCPCChemicals

Balchem Launches Metalosate TEAM As Valuation And Growth Expectations Converge

Balchem has launched its Metalosate T.E.A.M. digital platform, a proprietary tool for advanced plant nutrition recommendations. The platform uses decades of company research to provide data driven micronutrient guidance for specialty crops. This free resource is aimed at helping advisors and growers refine yield, quality, and input efficiency during early and in-season planning. For investors watching Balchem (NasdaqGS:BCPC), the Metalosate T.E.A.M. launch adds a fresh development in the...
NasdaqGS:DBX
NasdaqGS:DBXSoftware

Is Dropbox (DBX) Still Attractive After Recent Share Price Recovery?

If you are wondering whether Dropbox shares still offer value at around US$26.74, you are not alone. This article is here to unpack what that price could mean for long term investors. The stock has returned 2.2% over the last 7 days and 7.0% over the last 30 days, while year to date returns sit at a 0.7% decline and the 1 year return is 5.8%, with a 3 year gain of 36.7% and a 5 year return of a 3.6% decline. Recent market attention on Dropbox has focused on how the business is positioned...
NYSE:VOYG
NYSE:VOYGAerospace & Defense

Voyager Technologies (VOYG) Is Down 5.2% After 2025 Losses Widen, Max Space Investment Announced - Has The Bull Case Changed?

Voyager Technologies recently reported its fourth-quarter and full-year 2025 results, showing sales rising to US$46.65 million for the quarter and US$166.42 million for the year, while losses widened, alongside issuing 2026 sales guidance of US$225 million to US$255 million and announcing a multi-million-dollar investment in Max Space to advance expandable space habitats supporting NASA’s Artemis Program. This combination of increased sales, deeper investment in space infrastructure, and a...
NYSE:NVRI
NYSE:NVRICommercial Services

Should Widening Losses Amid Stable Sales Require Action From Enviri (NVRI) Investors?

Enviri Corporation recently reported its fourth-quarter and full-year 2025 results, with full-year revenue of US$2,240.36 million versus US$2,343.14 million a year earlier and a wider net loss of US$167.60 million compared with US$129.65 million. The persistence of losses and higher loss per share, despite relatively steady revenue, highlights pressure on profitability and the company’s ongoing financial strain. With these earnings showing revenue slippage and a larger annual loss, we’ll now...
NasdaqCM:LTRX
NasdaqCM:LTRXCommunications

MediaTek Edge AI Expansion and EU Deal Could Be A Game Changer For Lantronix (LTRX)

In early March 2026, Lantronix Inc. expanded its embedded compute platform with new MediaTek Genio-based System-on-Module solutions and signed a European distribution partnership with Milan-based Melchioni Electronics to broaden sales and technical support across key EU markets. Together, the MediaTek-powered Edge AI modules and Melchioni’s regional reach materially widen Lantronix’s addressable markets, design-win potential and supply resilience across industrial and commercial IoT...
NYSE:AZZ
NYSE:AZZBuilding

Is AZZ (AZZ) Quietly Recasting Its Board to Sharpen Capital Allocation Discipline?

AZZ Inc. recently reshaped its governance, appointing Myers Industries CEO Aaron Schapper and Vistance Networks CEO Charles “Chuck” Treadway to its Board effective April 8, 2026, while long-time chair Dan Feehan stepped down in March and was succeeded by director Dan Berce, with Feehan remaining on the Board until July 2026. These board changes, alongside an expanded stock repurchase authorization and ongoing leadership refresh, highlight AZZ’s focus on strengthening oversight, capital...
NasdaqGS:ERII
NasdaqGS:ERIIMachinery

A Look At Energy Recovery (ERII) Valuation After PX Q650 Desalination Launch

Why the PX Q650 launch matters for Energy Recovery (ERII) investors Energy Recovery (ERII) has drawn fresh attention after launching its PX Q650 Pressure Exchanger for desalination, combining higher flow capacity, very high stated efficiency, and extended warranties aimed at long-life plant operations. See our latest analysis for Energy Recovery. The PX Q650 launch comes on the heels of Energy Recovery’s recent earnings update. It arrives at a time when the stock has seen a 4.81% 1 day share...